Echo Therapeutics said its Symphony tCGM device demonstrated a high accuracy rating in monitoring blood glucose levels and reported no adverse events in a clinical trial involving 20 patients with type 1 or type 2 diabetes. According to the study, 94.4% of the more than 2,600 glucose readings gathered using the device were found to be clinically accurate.
Echo's glucose monitoring device shows positive trial results
SmartBrief Job Listings for Health Care
|Vice President of Regulatory Affairs||
|Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX||
|Santa Clara, CA|
|Senior Director, Biostatistics||